Header Logo

Vu Hoang Tran

Concepts (121)

Back to Profile
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.


Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Acute Coronary Syndrome
5
2018
254
1.900
 Why?
Myocardial Infarction
5
2022
924
1.340
 Why?
Anxiety Disorders
2
2018
201
1.000
 Why?
Tachycardia, Ventricular
2
2018
131
0.990
 Why?
Patient Discharge
2
2018
522
0.840
 Why?
ST Elevation Myocardial Infarction
3
2022
96
0.800
 Why?
Non-ST Elevated Myocardial Infarction
2
2018
33
0.710
 Why?
Circulating Tumor DNA
4
2025
10
0.680
 Why?
Nutrition Surveys
2
2017
145
0.620
 Why?
Percutaneous Coronary Intervention
1
2022
226
0.580
 Why?
Early Detection of Cancer
4
2025
325
0.550
 Why?
Hyperglycemia
1
2018
105
0.540
 Why?
Ventricular Fibrillation
1
2018
107
0.540
 Why?
Deficiency Diseases
1
2017
13
0.530
 Why?
Iodine
1
2017
20
0.530
 Why?
Arrhythmias, Cardiac
1
2018
163
0.520
 Why?
Patient Admission
1
2018
199
0.500
 Why?
Cardiovascular Agents
1
2017
106
0.490
 Why?
Drug Utilization
1
2017
208
0.480
 Why?
Depressive Disorder
1
2018
288
0.480
 Why?
Hospital Mortality
2
2022
879
0.450
 Why?
Length of Stay
1
2017
831
0.410
 Why?
Aged
13
2025
14942
0.400
 Why?
Coronary Artery Disease
1
2017
326
0.400
 Why?
Middle Aged
12
2025
18262
0.390
 Why?
Healthcare Disparities
1
2017
403
0.370
 Why?
Risk Factors
7
2018
5441
0.370
 Why?
Female
16
2025
34115
0.350
 Why?
Male
14
2025
31067
0.350
 Why?
Incidence
4
2018
1410
0.350
 Why?
Biomarkers, Tumor
5
2025
525
0.340
 Why?
Prognosis
4
2018
1793
0.320
 Why?
Massachusetts
5
2018
2149
0.320
 Why?
Atrial Fibrillation
2
2018
872
0.320
 Why?
Humans
23
2025
65536
0.290
 Why?
Cell-Free Nucleic Acids
2
2025
14
0.280
 Why?
Prospective Studies
5
2025
3355
0.250
 Why?
Time Factors
3
2018
3788
0.250
 Why?
DNA Methylation
2
2025
304
0.240
 Why?
Neoplasms
3
2025
1415
0.230
 Why?
Logistic Models
2
2018
1282
0.210
 Why?
Aged, 80 and over
3
2018
5609
0.210
 Why?
Patient Readmission
2
2018
446
0.210
 Why?
Pseudomonas Infections
1
2023
54
0.200
 Why?
Liver Neoplasms
2
2023
311
0.200
 Why?
Prevalence
2
2017
1441
0.190
 Why?
Biomarkers
2
2018
1473
0.180
 Why?
Exome
1
2021
78
0.170
 Why?
Carcinoma, Hepatocellular
1
2023
184
0.170
 Why?
Risk Assessment
2
2018
2101
0.170
 Why?
Pneumonia
1
2023
293
0.170
 Why?
Gene Frequency
1
2020
124
0.160
 Why?
Coronary Artery Bypass
1
2022
298
0.160
 Why?
United States
3
2018
8131
0.160
 Why?
Cardiovascular Diseases
2
2018
866
0.160
 Why?
Cardiac Catheterization
1
2022
305
0.160
 Why?
Genetic Testing
1
2020
142
0.150
 Why?
Alleles
1
2020
457
0.150
 Why?
Mutation
2
2025
2680
0.150
 Why?
Theranostic Nanomedicine
1
2018
9
0.140
 Why?
Radiation-Sensitizing Agents
1
2018
16
0.140
 Why?
Odds Ratio
2
2018
764
0.140
 Why?
Genotype
1
2020
679
0.140
 Why?
Leukocyte Count
1
2018
101
0.140
 Why?
Vietnam
3
2025
181
0.140
 Why?
Gadolinium
1
2018
110
0.130
 Why?
Hospitalization
2
2022
1393
0.130
 Why?
Mortality
1
2018
161
0.130
 Why?
Protective Factors
1
2017
33
0.130
 Why?
Herpes Zoster
1
2017
24
0.130
 Why?
Cerebrovascular Disorders
1
2017
81
0.130
 Why?
Chi-Square Distribution
1
2017
416
0.120
 Why?
Breast Neoplasms
1
2025
1229
0.120
 Why?
Linear Models
1
2017
409
0.120
 Why?
Blood Glucose
1
2018
492
0.120
 Why?
Cohort Studies
2
2021
2632
0.120
 Why?
Medication Adherence
1
2017
199
0.120
 Why?
Survival Rate
1
2018
861
0.120
 Why?
Drug Monitoring
1
2017
205
0.120
 Why?
Follow-Up Studies
2
2018
2511
0.120
 Why?
Multivariate Analysis
1
2017
938
0.110
 Why?
Stroke
3
2018
1215
0.100
 Why?
Disease Progression
1
2018
1218
0.100
 Why?
Anticoagulants
1
2018
519
0.100
 Why?
Adult
5
2025
17411
0.100
 Why?
Registries
1
2017
904
0.100
 Why?
Health Services Accessibility
1
2018
595
0.100
 Why?
Nanoparticles
1
2018
545
0.090
 Why?
Depression
1
2018
916
0.090
 Why?
Quality of Life
1
2018
1270
0.080
 Why?
Treatment Outcome
2
2018
5818
0.080
 Why?
Retrospective Studies
2
2025
6880
0.080
 Why?
Cross-Sectional Studies
1
2017
2699
0.080
 Why?
Tobramycin
1
2023
7
0.050
 Why?
DNA, Neoplasm
1
2023
63
0.050
 Why?
Rabbits
1
2023
337
0.050
 Why?
Pseudomonas aeruginosa
1
2023
111
0.050
 Why?
Microbial Sensitivity Tests
1
2023
214
0.050
 Why?
Shock, Cardiogenic
1
2022
107
0.040
 Why?
Hospitals
1
2022
391
0.040
 Why?
Genome-Wide Association Study
1
2020
369
0.040
 Why?
Publication Bias
1
2018
21
0.040
 Why?
Georgia
1
2018
88
0.040
 Why?
Sex Distribution
1
2018
250
0.030
 Why?
Age Distribution
1
2018
259
0.030
 Why?
Polymorphism, Single Nucleotide
1
2020
511
0.030
 Why?
Herpes Zoster Ophthalmicus
1
2017
6
0.030
 Why?
Forecasting
1
2018
232
0.030
 Why?
Anti-Bacterial Agents
1
2023
821
0.030
 Why?
Head and Neck Neoplasms
1
2018
165
0.030
 Why?
Administration, Oral
1
2018
376
0.030
 Why?
Phenotype
1
2020
1241
0.030
 Why?
Venous Thromboembolism
1
2018
148
0.030
 Why?
Brain Neoplasms
1
2018
316
0.030
 Why?
Comorbidity
1
2018
1123
0.030
 Why?
Melanoma
1
2018
334
0.030
 Why?
Randomized Controlled Trials as Topic
1
2018
801
0.030
 Why?
Pregnancy
1
2020
2432
0.020
 Why?
Animals
2
2023
21533
0.020
 Why?
Surveys and Questionnaires
1
2018
2781
0.020
 Why?
Mice
1
2018
11209
0.010
 Why?
Tran's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts (121)
Explore
_
Co-Authors (18)
Explore
_
Similar People (60)
Explore
_
Same Department Expand Description
Explore
_